Quarterly report pursuant to Section 13 or 15(d)

Net Loss Per Share

v3.22.1
Net Loss Per Share
3 Months Ended
Mar. 31, 2022
Net Loss Per Share  
Note 2. Net Loss Per Share

Note 2. Net Loss Per Share

 

Basic net loss per share is computed using the weighted-average number of common shares outstanding during the year except that it does not include unvested common shares subject to repurchase or cancellation. Diluted net income per share is computed using the weighted-average number of common shares and, if dilutive, potential common shares outstanding during the period. Potential common shares consist of the incremental common shares issuable upon the exercise of stock options, warrants and convertible preferred shares (see Note 6. Stockholders’ Equity and Stock-Based Compensation). The common stock equivalents of performance-based milestone compensation arrangements are included as potentially dilutive shares only if the performance condition has been met as of the end of the reporting period.

 

The treasury stock method is used in calculating diluted EPS for potentially dilutive stock options and share purchase warrants, which assumes that any proceeds received from the exercise of in-the-money stock options and share purchase warrants would be used to purchase common shares at the average market price for the period, unless including the effects of these potentially dilutive securities would be anti-dilutive.

The following table sets forth the computation of the basic and diluted loss per share (dollars in millions, except share data):

 

 

 

Three Months Ended

 

 

 

March 31,

 

 

 

2022

 

 

2021

 

Basic

 

 

 

 

 

 

Numerator:

 

 

 

 

 

 

Net loss attributable to common stockholders

 

$ (2.0 )

 

$ (2.2 )

Denominator:

 

 

 

 

 

 

 

 

Weighted-average common shares outstanding

 

 

10,283,280

 

 

 

6,589,392

 

Basic net loss per share

 

$ (0.20 )

 

$ (0.33 )

 

 

 

 

 

 

 

 

 

Diluted

 

 

 

 

 

 

 

 

Numerator:

 

 

 

 

 

 

 

 

Net loss attributable to common stockholders, basic

 

$ (2.0 )

 

$ (2.2 )

Effect of dilutive securities

 

 

 

 

 

 

Net loss, diluted

 

$ (2.0 )

 

$ (2.2 )

Denominator:

 

 

 

 

 

 

 

 

Weighted average common shares outstanding - basic

 

 

 

 

 

 

 

 

Potential common share issuances:

 

 

10,283,280

 

 

 

6,589,392

 

Incremental dilutive shares from equity instruments (treasury stock method)

 

 

 

 

 

 

Weighted-average common shares outstanding

 

 

10,283,280

 

 

 

6,589,392

 

Diluted net loss per share

 

$ (0.20 )

 

$ (0.33 )

 

The following outstanding securities have been excluded from the computation of diluted weighted shares outstanding for the periods noted below, as they would have been anti-dilutive due to the Company’s losses for the three months ended March 31, 2022 and 2021 and also because the exercise price of certain of these outstanding securities was greater than the average closing price of the Company’s common stock.

 

 

 

Three Months Ended

 

 

 

March 31,

 

 

 

2022

 

 

2021

 

Warrants outstanding

 

 

45,577

 

 

 

59,242

 

Stock options outstanding

 

 

543,297

 

 

 

515,136

 

RSAs outstanding

 

 

188,588

 

 

 

 

RSUs outstanding

 

 

 

 

 

243,800

 

Series A convertible preferred stock to common shares

 

 

 

 

 

80,712

 

Series B convertible preferred stock to common shares

 

 

 

 

 

276,846

 

Total

 

 

777,462

 

 

 

1,175,736